Copyright
©The Author(s) 2021.
World J Clin Cases. Aug 26, 2021; 9(24): 7009-7021
Published online Aug 26, 2021. doi: 10.12998/wjcc.v9.i24.7009
Published online Aug 26, 2021. doi: 10.12998/wjcc.v9.i24.7009
β | P value | HR | 95.0%CI | ||
Lower | Upper | ||||
LIRADS | 0.356 | 0.019 | 1.428 | 1.059 | 1.925 |
AFP | 0.436 | 0.000 | 1.547 | 1.245 | 1.922 |
Diameter | 0.116 | 0.003 | 1.123 | 1.041 | 1.211 |
Age | 0.009 | 0.319 | 1.009 | 0.991 | 1.027 |
ALT | 0.007 | 0.075 | 1.007 | 0.999 | 1.014 |
AST | 0.003 | 0.322 | 1.003 | 0.997 | 1.008 |
PLT | 0.002 | 0.225 | 1.002 | 0.999 | 1.005 |
TBIL | 0.019 | 0.052 | 1.019 | 1.000 | 1.039 |
Start time | -0.032 | 0.229 | 0.968 | 0.918 | 1.021 |
Out time | -0.001 | 0.595 | 0.999 | 0.996 | 1.002 |
Sex | -0.270 | 0.312 | 0.763 | 0.453 | 1.288 |
- Citation: Tu HB, Chen LH, Huang YJ, Feng SY, Lin JL, Zeng YY. Novel model combining contrast-enhanced ultrasound with serology predicts hepatocellular carcinoma recurrence after hepatectomy. World J Clin Cases 2021; 9(24): 7009-7021
- URL: https://www.wjgnet.com/2307-8960/full/v9/i24/7009.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i24.7009